HomeELDN • NASDAQ
add
Eledon Pharmaceuticals Inc
Previous close
$2.89
Day range
$2.87 - $2.97
Year range
$2.30 - $5.54
Market cap
171.86M USD
Avg Volume
194.52K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.96M | 65.28% |
Net income | -6.50M | 72.51% |
Net profit margin | — | — |
Earnings per share | -0.08 | 76.47% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 124.88M | 191.36% |
Total assets | 161.31M | 99.59% |
Total liabilities | 46.73M | -51.09% |
Total equity | 114.58M | — |
Shares outstanding | 59.88M | — |
Price to book | 1.51 | — |
Return on assets | -26.52% | — |
Return on capital | -38.29% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -6.50M | 72.51% |
Cash from operations | -16.06M | -83.73% |
Cash from investing | 3.89M | -60.22% |
Cash from financing | 115.00K | 11,400.00% |
Net change in cash | -12.05M | -1,255.61% |
Free cash flow | -12.92M | -178.28% |
About
Founded
2004
Headquarters
Website
Employees
31
